Activation of protein kinase C induces differentiation in the human T-lymphoblastic cell line MOLT-3. by Yamauchi, Y. et al.
Br. J. Cancer (1989), 60, 15-19
C The Macmillan
Activation of protein kinase C induces differentiation in the human
T-lymphoblastic cell line MOLT-3
Y. Yamauchi, K. Nagasawa, T. Mayumi, T. Horiuchi & Y. Niho
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812,
Japan.
S_uany We attempted to determine whether or not activation of calcium phospholipid-dependent protein
kinase C (PKC) is associated with the induction of differentiation by 12-O-tetradecanoylphorbol-13-acetate
(TPA) in the human T-lymphoblastic cell line MOLT-3. PKC activities were assayed in MOLT-3 and its five
subclones resistant to TPA-induced cell differentiation. The cytosolic PKC activities of TPA-resistant
subclones were 36-53% of that of the parental MOLT-3 cells. TPA treatment led to a rapid decrease in PKC
activities in the cytosol, together with a concomitant increase in PKC activities in the particulate fraction, in
both MOLT-3 and a TPA-resistant subclone. Thus, translocation of PKC from the cytosol to the membrane
occurred following treatment with TPA, in both cell lines. However, the amount of PKC translocated from
the cytosol to particulate fraction for 60min in a TPA-resistant subclone was about 20% of that of the
parental MOLT-3 cells. These findings suggest that the quantity of cytosolic PKC activity and the extent of
translocation may relate to responses to TPA-induced cell differentiation in this T-cell line.
TPA, a most potent tumour promoter phorbol ester, exerts
its effect on tissues and cultured cells (Diamond et al., 1980).
The initial event in its action involves binding to the specific
receptors on cell membrane, now identified to be calcium
phospholipid-dependent PKC (Berridge, 1984; Niedel et at.,
1983; Nishizuka et al., 1984; Parker et al., 1984; Sando &
Young, 1983; Shoyab & Todaro, 1980).
We reported TPA-induced differentiation in human
malignant T-cell lines MOLT-3 and Jurkat and analysed the
processes in the differentiation, using T-cell differentiation
markers such as cell proliferation, E rosette formation,
terminal deoxynucleotidyl transferase activity, monoclonal
OKT antigen expression and morphological changes
(Nagasawa & Mak, 1980, 1982; Nagasawa et al., 1981a,b).
Using MOLT-3 and its subclones resistant to TPA
induction, we also found that the receptors for phorbol ester
play an important role at the initial process of induction of
cell differentiation (Mayumi et al., 1988). Our main interest
has been whether activation of PKC mediates the signals for
differentiation as it does in the process of stimulation or
proliferation in various cell systems (Kaibuchi et al., 1983;
Kajikawa et al., 1983; Malaisse et al., 1983; Rozengurt et al.,
1984), including human mature T-lymphocytes (Isakov et al.,
1987; Manger et al., 1987).
In the induction of differentiation in the promyelocytic
leukaemia cell line HL-60, a line most often used as a model
of differentiation, some investigators suggested that TPA
exerts an induction effect through PKC as a signal mediator
(Anderson et al., 1985; Vandenbark et al., 1984), whereas
others refuted this (Kreutter et al., 1985). Vandenbark et al.
(1984) first proposed that the TPA-induced maturation of
HL-60 might be mediated by the activation of intracellular
PKC whereas Kreutter et al. (1985) observed a dissociation of
the activation of PKC and the induction of cell maturation,
determined using I-oleoyl-2-acetylglycerol, a synthetic com-
pound which also directly activates PKC. However, little is
known of the role of PKC in the induction of T-lymphocyte
differentiation.
Activation of PKC is associated with its translocation
from the cytosol to the membrane (Kraft et al., 1982; Kraft
& Anderson, 1983). Kraft et al. (1982) and Kraft and
Anderson (1983) demonstrated that TPA caused a trans-
location of PKC from the cytosol to the membrane in intact
cells and these data were supported by other investigators
(Shoji et al., 1987). Homma et al. (1986) also found that a
translocation of PKC from the cytosol to the membrane
fractions occurred in HL-60 cells, in response to TPA,
whereas it did not occur in the TPA-resistant HL-60 variant
cells, hence the translocation of PKC was presumed to be
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closely related to the TPA-induced differentiation in HL-60.
We have now examined the role of PKC, in particular its
activation and subcellular distribution, in the TPA-induced
differentiation of MOLT-3.
Materials and meds
Chemicals
Histone HI (type III-S), phosphatidylserine (PS), TPA and
ATP were purchased from Sigma Chemical Co. (St Louis,
MO). y-32P-ATP (3,000 Cimmol-1), obtained from
Amersham Japan Ltd was diluted with non-radioactive ATP
to 100c.p.m.pmol-1 just before use. TPA was dissolved at
2rmgml-1 in dimethylsulphoxide (DMSO) or 100mgl 1- in
acetone and stored at -20'C.
Cell culture
The human T-lymphoblastic cell line MOLT-3 was obtained
from E. Gelfand (Hospital for Sick Children, Toronto,
Canada). MOLT-3 subclones (ROI, R02, R03, R04 and R05)
resistant to the growth inhibition effect by TPA were
obtained from colonies formed in 0.8% methylcellulose
containing 16nM TPA and 15% fetal calf serum (FCS), as
described (Mayumi et al., 1988). These cells were maintained
in RPMI 1640 medium supplemented with 10% FCS,
100mgl-1 streptomycin and 100Uml1- penicillin. The
concentration of acetone used in the cell culture did not
exceed 0.01%.
Terminal deoxynucleotidyl transferase assay
The terminal deoxynucleotidyl transferase (TdT) activities in
MOLT-3 cells and its subclones were measured by
biochemical assay, as described (Okamura et al., 1978).
Subcellular fractionation
MOLT-3 or TPA-resistant cells (3-6 x 107 cells) maintained
without TPA for at least a month were used in the following
study. All subsequent steps were done at 4 C. The cells were
washed twice with divalent cation-free PBS, resuspended in
3ml homogenising buffer (20mM Tris, pH7.5, 2mM EDTA,
0.5mM EGTA, 0.33M sucrose, 2mM phenylmethylsulphonyl
fluoride (PMSF) and 50mM 2-mercaptoethanol) and
sonicated with a Branson Model Sonifier for 45s at 20W.
The homogenates were centrifuged for 60min at 100,000g
and the supernatant served as the cytosol fraction. The
pellets were washed with homogenising buffer and re-
centrifuged for 60min at 100,000g. The pellet was used for
Br. J. Cancer (I989), 60, 15-19 (Cl The Macmifan Press Ltd., 198916 Y. YAMAUCHI et al.
the particulate fraction. PKC in the particulate fraction was
extracted with 0.5% Nonidet P40, overnight on ice.
PKC from the cytosol fractions was partially punrfied by
applying cell extracts from MOLT-3 and the TPA-resistant
subclone ROI to a small DEAE-sepharose column
(0.9 x 2.4cm) equilibrated with buffer A (20mM Tris, pH 7.5,
2mM EDTA, 0.5mM EGTA and 2mM PMSF). After sample
application, the column was washed with 30ml of buffer A
and the enzyme was eluted with a linear gradient of NaCI
(0-0.3M, total volume of 30ml, flow rate 60mlh-1).
Fractions of 1.0ml were collected and S0pl of each fraction
was used to measure the activity of PKC. On the basis of the
elution profile obtained, the cytosol and particulate
preparations were fractionated on a DEAE-sepharose
column, using a one step with 0.15 M NaCl in 4ml of buffer
A, and PKC activities were determined.
Subcellular distribution of PKC
Intact MOLT-3 cells and the TPA-resistant subclone ROI
(3 x107 cells) were preincubated at 37 C for 30min, then
TPA was added at a final concentration of 16nM. The cells
were incubated for various time periods up to 60min and
washed twice with ice-cold PBS. PKC in the cytosol and the
particulate fraction was partially purified on a DEAE-
sepharose column, using a one step with 0.15 M NaCI, and
PKC activity was determined.
PKC assay
PKC activity was determined by measuring the
incorporation of 32P from _y-32P-ATP into histone HI, as
described (Kikkawa et al., 1982). The reaction mixture, in a
final volume of 250 pl, consisted of 80pgml-1 PS, 20mM
Tris (pH 7.5), 0.1 mM CaCl2, 5mM magnesium acetate,
2.5 nmol y-32P-ATP (100c.p.m.pmoli), 50pg of histone HI
and 50y of sample in the absence or presence of IjgmmlP
TPA. Incubation was carried out for 5min at 30'C. The
reaction was terminated by the addition of 25% trichloro-
acetic acid. The acid-precipitated matenrals were collected on
a membrane filter and counted for radioactivity. PKC
activity was determined by subtracting the activity measured
in the absence of TPA from that measured in its presence
and expressed as nmol Of 32P transferred to histone H1 per
min at 30-C per 108 cells. Protein was estimated by the
method of Bradford (1976). Bovine serum albumin was used
as the standard.
Results
Characteristics of TPA-resistant subclones
The proliferation of MOLT-3 in the presence of 16nM TPA
was reduced with 3 days of culture, after which the cells
grew slowly up to day 9, with a viability exceeding 90%, as
determined by trypan blue dye exclusion. Thus, the TPA was
not toxic to these MOLT-3 cells (Figure la). The five TPA-
resistant subclones of MOLT-3 obtained in methylcellulose
containing TPA grew equally well in suspension cultures,
with or without 16nM TPA (Figure lb). The form and size
of these TPA-resistant subclones did not differ from those of
the parental MOLT-3. The resistance of those clones to TPA
was not lost for up to several months, even in continuous
culture without TPA.
The presence of TdT is characteristic of prothymocytes
and is absent in mature T-lymphocytes (Bollum, 1979). The
level of the enzyme of MOLT-3 was reduced dramatically in
the presence of 16nM TPA, reaching a level of 12% of the
control culture at 3 days, whereas the level of the enzyme of
TPA-resistant subclones remained high after TPA
stimulation for 3 days (Table I). These results indicate that
the parental MOLT-3 reaches a more differentiated state
whereas the TPA-resistant subclones remain immature in the
presence of TPA.
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Fgwe 1 Growth curves of MOLT-3 (a) and TPA-resistant
subclone (ROI) (b) in the presence (0 0) or absence
(Q-Q) of 16nM TPA. Each point is the mean+s.e. of
viable cell number of two separate experiments. R02, R03, R04
and R05 proliferated equally well, with or without TPA, as ROI.
Table I Terminal deoxynucleotidyl transferase
(TdT) activities of MOLT-3 and TPA-resistant
subclones
3 dais after
Clones Dal 0 TPA stimulation
MOLT-3 60.6+ 7.8 7.1 + 2.9
ROI 199+ 3.2 125+ 9.4
R02 106+ 9.7 125+13.4
R03 110+ 7.7 106+14.9
R04 118+15.7 96.7+ 7.3
R05 88.7+14.4 70.0+ 8.7
TdT activity; unit per IGW cells. One unit of
enzyme activity incorporates in 1 h 1 nmol of
dGMP into acid-precipitable material at 37-C,
using oligo(dA)1218 as a primer. The values are
expressed as mean+s.e. of three separate
expenments.
Elution profile of cvtosolic PKC of MOLT-3 and TPA-
resistant subclone ROJ
Cytosol preparations of MOLT-3 were fractionated on
DEAE-sepharose columns using a linear gradient and
column fractions were assayed for PKC activity. The PKC
activity eluted at a concentration of 0.06-0.16M with a peak
at 0.10M NaCI (Figure 2a). Cytosol preparations of ROI
showed an elution profile of PKC, in a similar fashion and
with a peak at 0.10M NaCl (Figure 2b). However, the
amount of PKC activity in ROI was 40% of that of the
parental MOLT-3. The baseline of PKC activity in ROI was
lower than that of MOLT-3, thereby indicating that PKC in
ROI was not already activated. To determine whether PKC
activities of TPA-resistant subclones were less than those ofPROTEIN KINASE C AND T-LYMPHOBLAST 17
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Fugre 2 PKC activities on DEAE-sepharose chromatography
of MOLT-3 (a) and TPA-resistant subclone (ROI) (b). Cytosol
from 108 Ocells (MOLT-3, 10.0mg; RO1, 10.1 mg) were applied to
and eluted from the column, as described in Materials an
wtods. PKC activity was determined as described with 50d1
aliquots from the indicated effluent in the presence (@-*)
or absence (Q-Q) of Iugmrl- TPA, with 0.1mM Ca2+
and 80pgml-1 PS and expressed as c.p.m. 32P incorporated into
histone HI for 5min per 50.ul sample. , NaCl
concentration.
parental MOLT-3, we assayed the cytosolic PKC activities in
MOLT-3 and TPA-resistant subclones by partial purification
on DEAE-sepharose columns with a one step with 0.15M
NaCI in 4ml of buffer A. The amount of cytosolic PKC
activity of five TPA-resistant subclones RO1, R02, R03, R04
and R05 was 1,171 +264(36%), 1,725±264 (53%), 1,522± 119
(47%), 1,689±269 (52%) and 1,634±367 (50%) nmol 32P
incorporated into histone HI per min per 108 cells,
respectively, all being significantly low compared to
3,247+467 (100%) in the parental MOLT-3. The data are
expressed as mean+s.d., n=7, 7, 4, 4, 4 and 4; MOLT-3,
RO1, R02, R03, R04 and R05, respectively. Therefore, PKC
activities in TPA-resistant subclones were less than that in
MOLT-3.
Effect of TPA on subcellular distribution of PKC
To investigate the activation of PKC, the effect of TPA on
the subcellular distribution of PKC in MOLT-3 and the
TPA-resistant subclone ROI was examined (Figure 3). Most
(98-99%) of the PKC activity was found in the cytosol and
there was little PKC activity in the particulate fraction, in
both cell lines. The stimulation with 16nM TPA in the
parental MOLT-3 resulted in a 50% decrease in cytosolic
PKC activity within 5min, followed by a gradual decline to
10% of the initial level at 60min (Figure 3a) and a
concomitant increase in PKC activity in the particulate
fraction occurred (Figure 3b). A similar change of sub-
cellular PKC distribution also occurred in ROI. Thus, the
PKC activities in the cytosol and particulate fraction
changed inversely, in both cell lines and in a time dependent
manner, indicating that the translocation of PKC from the
cytosol to the particulate fraction was caused by TPA
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Fugwe 3 Time course of PKC activities in the cytosolic (a) and
particulate (b) fraction. MOLT-3 (@-*) and ROI
(0 O) were incubated for the indicated times at 37-C with
16nM TPA in 0.0005% DMSO. Each point is the mean+s.e. of
three separate experiments. PKC activity is expressed as nmol
32P incorporated into histone HI per 108 cells.
stimulation. However, the amount of decrease for 60mn
was 0.57nmolmin-' per 108 cells in ROI, 24% of
2.40nmolmin-m per 108 cells in MOLT-3 (Figure 3a) and
the amount of increase for 60min was 0.51 nmolmin- per
108 cells in ROI, 20% of 2.60nmolmin-' per 108 cells in
MOLT-3 (Figure 3b). There was no detectable PKC activity
in the cytosol and particulate fractions of both MOLT-3 and
RO1 at 24, 72 and 120h after addition of 16nM TPA (data
not shown). DMSO (0.0005%) had no apparent effect on
translocation in MOLT-3 or the TPA-resistant subclones
(data not shown).
To investigate the role of phorbol ester receptors or PKC in
case of TPA-induced differentiation, a comparison between
TPA-sensitive and resistant subclones should be of great use.
The TPA-resistant subclones from MOLT-3 proliferated in
either the presence or absence of TPA. The TPA-resistance
was also confirmed by the assay of TdT activities. TdT
activities in these subclones remained high even in the
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presence of TPA, whereas they were reduced in the sensitive
parental MOLT-3 cells in 3 days' culture with TPA. These
results indicated that the TPA-resistant subclones were not
induced to differentiate by TPA and remained immature.
In previous work, we found that the amount of phorbol
ester binding to TPA-resistant subclones from MOLT-3 was
about half that of the parental MOLT-3, presumably due to
a low concentration of receptors for phorbol esters, as
assayed by Scatchard analysis (Mayumi et al., 1988). Thus,
we concluded that the number of receptors for phorbol
esters played an important role in the induction of differ-
entiation in MOLT-3 cells by TPA. Several studies have
shown that the receptors for phorbol esters are copurified
with PKC (Ashendel et al., 1983; Niedel et al., 1983). The
enzyme is now thought to be a major receptor for phorbol
esters (Sando & Young, 1983; Sharkey et al., 1984) and also
one of the major signal mediators from the cell membrane to
the nucleus (Nishizuka, 1984; Berridge, 1984). This prompted
us to investigate whether PKC was related to the TPA-
induced differentiation in MOLT-3. The levels of PKC in the
cytosol in five TPA-resistant subclones were about half those
in the parental MOLT-3. A similar result is shown in Figure
2, where the baseline of PKC activity without TPA is also
lower in the TPA-resistant subclone ROI than in the parental
MOLT-3. These results may reflect a decrease in number of
phorbol ester receptors in TPA-resistant subclones of
MOLT-3, as already noted (Mayumi et al., 1988).
Phorbol esters with tumour-promoting activity cause a
translocation of PKC from the cytosol to the membrane
fraction in various cell systems (Kraft et al., 1982; Kraft &
Anderson, 1983; Shoji et al., 1987) including human mature
T-ells (Isakov et al., 1987; Manger et al., 1987). In cell
differentiation systems, however, the role of PKC is not well
understood. In the human promyelocytic leukaemia cell line
HL-60, Vandenbark et al. (1984) found that the TPA-
induced differentiation was mediated by PKC, whereas other
investigators demonstrated that mediator(s) other than or in
addition to the activation of PKC may be required for the
induction of differentiation (Kreutter et al., 1985). In
contrast, however, the role of PKC in TPA-induced differ-
entiation in T-lymphocytes is less well understood. We found
that a translocation of PKC oceurred in both TPA-resistant
cells and TPA-sensitive MOLT-3 cells as seen in other cells
(Kraft et al., 1982; Shoji et al., 1987). However, it should
be emphasise that the amount of PKC translocated
from the cytosol to the particulate fraction for 60min in ROI
was only 20% of that in the MOLT-3 cells. The amount of
cytosolic PKC and of its translocation may be a main factor
associated with the induction of cell differentiation.
These results differ from those shown by Homma et al.
(1986), in that the level of cytosolic PKC in TPA-resistant
HL-60 variant cells was as high as that in TPA-sensitive HL-
60 cells and that translocation of PKC to the membrane did
not occur in the resistant cells. In contrast, the results
obtained by Shoji et al. (1987), who used the acute myelo-
blastic leukaemia cell line KG-I, are close to our
observations. They showed that cytosolic PKC activity in the
TPA-resistant subclone KG-la was about one third of that in
the parental TPA-sensitive KG-I cells, despite similar
patterns of translocation of PKC, in both lines. These
discrepancies may be related to different cell systems. With
respect to the phorbol ester receptors, there is also a
difference between MOLT-3 and HL-60. The down
regulation of phorbol ester receptors by TPA was seen both
in TPA-resistant cells and in the parental MOLT-3 (Mayumi
et al., 1988), whereas it was not observed in TPA-resistant
cells from HL-60 (Solanki et al., 1981). The down regulation
of phorbol ester receptors was observed within 15min after
stimulation with TPA (Mayumi et al., 1988). The precise
relationship between the down regulation of phorbol ester
binding and PKC translocation is unclear, but both events
may be related.
The role of PKC after the onset of cell differentiation is
also unclear. There was no detectable PKC activity in the
cytosol and particulate fractions for up to 120h after
treatment with 16nM TPA, in both MOLT-3 and ROI.
These results may reflect the continued translocation of PKC
from the cytosol to the membrane and the degradation of
membrane-associated PKC (Ballester & Rosen, 1985).
While this study provides no direct evidence that PKC
translocation from the cytosol to the membrane fraction
causes differentiation in MOLT-3, nevertheless, the existence
of differences in the amount of cytosolic PKC, the amount
of PKC translocation and the number of phorbol ester
receptors between TPA-resistant subclones and the parental
MOLT-3 cells do suggest that PKC plays an important role
in the induction of differentiation by TPA in this T-
lymphoblastic cell line MOLT-3.
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